A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma
Clinical trial NCT02138292 · COMPLETED
Trial details
- NCT number
- NCT02138292
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2017-02-23
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.